The inclusion of Proginorm OVO and Proginorm GESTA into the complex therapy of the threat of abortion has led to a significant improvement in its further course. When using progesterone up to 16 weeks of pregnancy, the frequency of the threat of abortion in the second half decreased 1.5 times and 2 times – the need to prescribe β-adrenomimetics. prolonged use of progesterone allowed to reduce 2.6 times the frequency of threat of premature birth and 7 times to reduce the frequency of use of β-adrenomimetics.

High efficacy, good tolerability, cost-effectiveness, and patient satisfaction with the results of treatment with Proginorm OVO and Proginorm GESTA allow recommending Proginorm OVO and Proginorm GESTA for use in pregnancy miscarriage of women with uterine leiomyoma